Header Logo

Connection

JOHN KIRKWOOD to Sirolimus

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Sirolimus.
JOHN KIRKWOOD
Connection Strength
0.022
Sirolimus
  1. Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438). Clin Cancer Res. 2012 Feb 15; 18(4):1129-37.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.